Chelation Therapies: A Chemical and Biochemical Perspective
Keywords: (TETA); 2,3-dimercaptopropanol (BAL); 2-2'-methilenedi-8-quinolinol; Alzheimer disease; Bertrand diagram; Bioinorganic Chemistry; CDTA; Chelation Therapies; Cu/metallothionein; D-penicillamine; DTPA; Desferrioxamine B; Dihydrolipoic Acid (DHLA); Ethylenediaminetetraacetic acid (EDTA); Huntington's disease; Lipoic Acid (LA); Metal Intoxications; Monoalkyl Esters of DMSA; Parkinson's disease; Polyaminopolycarboxylic Acids; TTHA; Toxic metals; Vanadium Toxicity; Wilson Disease; atherosclerosis; autoimmune reactions; biolixiviation; biological effects; blood-brain-barrier; chelating agents; chelation therapy; chemical characteristics; clioquinol (CQ); deferasirox; deferiprone; hard-soft acid-base concept (HSAB); hepatocytes; hypocalcemia; ligand-to-metal interaction; macrophages; metal-based drugs; metal-protein attenuating compound (MPAC); nephritic syndrome; nephrotoxic; non-essential toxic elements; plaques; polyaminopolyarboxylic acids; potentiate cadmium toxicity; remediation; decon-tamination
Document Type: Research Article
Publication date: 2010-11-01
- Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.